Literature DB >> 16511416

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.

Jeanne Serpaggi1, Marie-Laure Chaix, Dominique Batisse, Caroline Dupont, Anaïs Vallet-Pichard, Hélène Fontaine, Jean-Paul Viard, Christophe Piketty, Elisabeth Rouveix, Christine Rouzioux, Laurence Weiss, Stanislas Pol.   

Abstract

BACKGROUND: Recent studies have suggested an increased risk of acute hepatitis C (HCV) infection in homosexual HIV-infected men and that early treatment with standard or pegylated interferon-alfa, alone or associated with ribavirin, significantly reduces the risk of chronic evolution in HIV-infected patients.
METHODS: A retrospective analysis of 12 HIV-infected patients who were consecutively diagnosed as developing acute HCV infection, defined by both seroconversion of anti-HCV antibodies and detection of serum HCV RNA in those with previous negative results. Ten of these patients received early antiviral treatment with standard or pegylated interferon-alfa, alone or associated with ribavirin.
RESULTS: The only risk factor in these patients was unprotected sexual intercourse with men. Acute HCV infection was asymptomatic in 10 patients, and the HCV genotype was 4d in 10 patients. The 10 genotype 4d viruses formed a monophylogenetic group and clustered separately from other local sequences of HCV genotype 4d, suggesting a common source of infection. None of the 10 patients who were treated early with antiviral therapy had a sustained virological response, as defined by undetectable HCV RNA 6 months after therapy.
CONCLUSIONS: There is a risk of sexual transmission of HCV in HIV-infected men who have sex with men; the cluster of HCV genotype 4d suggested a common source of infection and a failure in prevention counselling. Early treatment with standard interferon-alfa failed to prevent chronic evolution of HCV infection in this particular group of HIV-infected patients who had acquired this peculiar cluster of genotype 4 strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511416     DOI: 10.1097/01.aids.0000200541.40633.56

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  39 in total

Review 1.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

2.  Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Authors:  G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

3.  Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.

Authors:  Lynn E Taylor; Marisa Holubar; Kunling Wu; Ronald J Bosch; David L Wyles; John A Davis; Kenneth H Mayer; Kenneth E Sherman; Karen T Tashima
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

Review 4.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 5.  Dilemma of concepts and strategies for the prevention of spread of HIV in relation to human behavior, law and human rights.

Authors:  Reinhard H Dennin; Michael Lafrenz; Arndt Sinn; Lan-juan Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

Review 6.  Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.

Authors:  E Sagnelli; T Santantonio; N Coppola; M Fasano; M Pisaturo; C Sagnelli
Journal:  Infection       Date:  2014-03-12       Impact factor: 3.553

Review 7.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

Review 8.  Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Authors:  Todd H Driver; Norah Terrault; Varun Saxena
Journal:  J Gen Intern Med       Date:  2012-11-14       Impact factor: 5.128

9.  Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals.

Authors:  E Orsetti; S Staffolani; R Gesuita; G De Iaco; E Marchionni; L Brescini; P Castelli; F Barchiesi
Journal:  Infection       Date:  2013-05-24       Impact factor: 3.553

Review 10.  Advances in sexually transmitted infections of the gastrointestinal tract.

Authors:  Siew C Ng; Brian Gazzard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-25       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.